Why Is Consumer Health Firm Kenvue Stock Trading Lower Today?



Thursday, Kenvue Inc’s (NYSE:KVUE) fourth-quarter 2023 sales decreased 2.7% vs a 0.9% increase in the prior year to $3.67 billion, missing the consensus of $3.78 billion.

Organic growth declined 2.4% vs a 6.2% increase in the prior year. 

Net sales and Organic growth comprised 5.8% value realization and 8.2% volume declines. 

Approximately five points of the volume performance are attributable to an early and strong start to the cold, cough, and flu season last year, 2022 product discontinuations, and customer inventory reductions. 

The remaining approximately three points of volume performance are mainly due …

Full story available on Benzinga.com


Leave a Reply

Your email address will not be published. Required fields are marked *